Cited by 439Inflammatory Biomarkers in Disease PrognosisInflammation biomarkers and pathwaysSepsis Diagnosis and Treatment

Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update

Afari, Maxwell E., Bhat, Tariq·2016·Expert Review of Cardiovascular Therapy

Abstract

As we know, inflammatory and oxidative stresses have a role in the pathogenesis of cardiovascular disease. This knowledge has triggered many investigations targeted to inflammatory markers. One such example, the neutrophil to lymphocyte ratio (NLR), is an inexpensive and easily accessible inflammatory marker whose role in cardiovascular disease has been studied extensively in the past few years. The neutrophil lymphocyte ratio has been shown to predict cardiac arrhythmias as well as short- and long-term mortality in patients with acute coronary syndromes (ACS). It has correlated well with ACS risk prediction models such as the GRACE and SYNTAX scores. A higher NLR has also been associated with frequent congestive heart failure decompensation and long-term mortality. The neutrophil to lymphocyte ratio also appears to have a prognostic role in patients undergoing transaortic valve replacement and the progression of valvular heart diseases. Despite the science of inflammatory biomarkers having been described decades ago, NLR appears to be enjoying a renaissance as a cost-effective biomarker with immediate clinical predictability and prognostication.

Integrity signals

Registry

Crossref · 10.1586/14779072.2016.1154788

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NLR, PLR, and MLR are tests that can be easily measured using a complete blood count and can be used as markers of inflammatory processes in diseases such as autoimmune diseases.

    “Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are tests that can be easily measured using a complete blood count, can be used as markers of inflammatory processes in diseases such as autoimmune diseases, and have been shown to be prognostic indicators.3,4”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Afari, M. E., & Bhat, T.
Affiliations
Tufts University (US)
Corresponding author
Bhat, Tariq
Venue
Expert Review of Cardiovascular Therapy
Published
2016-03-04
Volume
14
Issue
5
Pages
573-577
ISSN
  • 1477-9072 (ISSN-L)
  • 1744-8344
OpenAlex
W2285799691
Cited by
439
References
0
Citations by year
2026: 31 · 2025: 48 · 2024: 55 · 2023: 63 · 2022: 72 · 2021: 63 · 2020: 46 · 2019: 26 · 2018: 19 · 2017: 10 · 2016: 6
FWCI
2.04
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Cardiovascular Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
Keywords
neutrophil-to-lymphocyte ratio, inflammatory markers, cardiovascular disease, acute coronary syndrome, cardiac arrhythmias, mortality prediction, congestive heart failure, aortic valve replacement, valvular heart disease, oxidative stress, GRACE risk score, SYNTAX score
MeSH terms
Cardiovascular Diseases, Heart Failure, Humans, Lymphocytes, Neutrophils, Prognosis, Risk, Biomarkers, Disease Progression, Acute Coronary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review